AGP Executive Report
Last update: an hour agoMedicare Fraud Crackdown: A federal grand jury indicted ND Medical Solutions owner Erekle Gugava in a $1.3B Medicare durable medical equipment scheme, alleging stolen patient identities and equipment never prescribed or received. Pediatric GLP-1 Surge: Use of GLP-1 drugs among children ages 8–11 with obesity (without diabetes) reportedly jumped 310-fold since 2019, raising questions about prescribing trends. Workforce Mental Health: NHS Practitioner Health will launch an online memorial wall for health and care workers who died by suicide, marking National Suicide Memorial Day. AI in Imaging: Harrison.ai is reportedly laying off staff as it pivots to a U.S. teleradiology push via Frontier Radiology, while a separate healthcare leader warns radiology may face AI disruption. Access After Drug Approval: Patient advocates say expanded-access programs can shut immediately after approval, delaying real-world access to newly approved pancreatic cancer therapy. Affordability Pressure: South Africa’s medical scheme gap persists, with 8.79M people earning enough to join but staying uninsured due to cost. Clinical Trial Milestone: Nyxoah implanted the first patient in its U.S. BREATHE study of the Genio sleep apnea device.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
